MEDNAX (MD) Misses Q4 EPS by 6c; Guides Q1 EPS Below the Street

MEDNAX (NYSE: MD) reported Q4 EPS of $1.00, $0.06 worse than the analyst estimate of $1.06. Revenue for the quarter came in at $831 million versus the consensus estimate of $842.15 million.

GUIDANCE:

MEDNAX sees Q1 2017 EPS of $0.86-$0.90, versus the consensus of $0.92.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c